Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 3)

v3.20.1
Stockholders' Equity (Details 3)
3 Months Ended
Mar. 31, 2020
$ / shares
shares
Stockholders' Equity Note [Abstract]  
Warrants outstanding and exercisable, beginning | shares 4,300,560
Warrants granted | shares 0
Warrants exercised/forfeited | shares 0
Warrants outstanding and exercisable, ending | shares 4,300,560
Weighted average exercise price outstanding and exercisable, beginning | $ / shares $ 1.77
Weighted average exercise price granted | $ / shares 0.00
Weighted average exercise price exercised/forfeited | $ / shares 0.00
Weighted average exercise price outstanding and exercisable, ending | $ / shares $ 1.77
Weighted average remaining contractual life, beginning 5 years 22 days
Weighted average remaining contractual life, ending 4 years 9 months 22 days